No Data
No Data
Morgan Stanley Initiates Crinetics(CRNX.US) With Buy Rating, Announces Target Price $70
Crinetics Pharma's Earnings Call: Progress Amid Challenges
A Quick Look at Today's Ratings for Crinetics(CRNX.US), With a Forecast Between $68 to $100
Earnings Call Summary | Crinetics(CRNX.US) Q4 2024 Earnings Conference
Express News | Citizens Capital Markets Maintains Market Outperform on Crinetics Pharmaceuticals, Lowers Price Target to $91
A Quick Look at Today's Ratings for Crinetics(CRNX.US), With a Forecast Between $68 to $97